Standard outcome measures for thymic malignancies

Journal of Thoracic Oncology

Volumn 5, Issue 12, 2010, Pages 2017-2023

  Huang, James ^b   Detterbeck, Frank C ^a   Wang, Zuoheng ^a   Loehrer, Patrick J ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mediastinal disease; Outcomes; Recurrence; Statistics; Thymic carcinoma; Thymoma

Indexed keywords

ANTINEOPLASTIC AGENT; PREDNISONE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CAUSE OF DEATH; CAUSE SPECIFIC SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE RELATED SURVIVAL; DISEASE SPECIFIC SURVIVAL; HUMAN; INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP; LUNG RESECTION; MEDICAL SOCIETY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SAMPLE SIZE; THYMOMA; THYMUS CANCER; TREATMENT RESPONSE;

EID: 78650516571     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181f13682     Document Type: Article

References (32)

1. de Jong WK, Blaauwgeers JLG, Schaapveld M, et al. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 2008;44:123-130. (Pubitemid 50009874)
2. Engel P, Marx A, Muller-Hermelink HK. Thymic tumours in Denmark. A retrospective study of 213 cases from 1970-1993. Pathol Res Pract 1999;195:565-570.
3. Detterbeck F, Parsons AM. Thymic tumors: a review of current diagnosis, classification, and treatment. In, Patterson GA, Cooper JD, Deslauriers J, Lerut A, Luketich JD, Rice TW, Pearson FG (eds). Thoracic and Esophageal Surgery, 3rd Ed. Philadelphia: Elsevier, 2008.Pp. 1589-1614.
4. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48: 2485-2492. (Pubitemid 12228012)
5. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994;44:359-367. (Pubitemid 24153752)
6. Gamondès JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardiothorac Surg 1991;5:124-131.
7. Yamakawa Y, Masaoka A, Hashimoto T, et al. A tentative tumor-nodemetastasis classification of thymoma. Cancer 1991;68:1984-1987.
8. Kornstein MJ, Curran WJ, Turrisi AT III, et al. Cortical versus medullary thymomas: a useful morphologic distinction? Hum Pathol 1988;19: 1335-1339.
9. Kornstein MJ. Controversies regarding the pathology of thymomas. Pathol Annu 1992;27:1-15.
10. Satariano WA, Ragland KE, Stephen VDE. Cause of death in men diagnosed with prostate carcinoma. Cancer 1998;83:1180-1188. (Pubitemid 28419072)
11. Penson DF, Albertsen PC, Nelson PS, et al. Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst 2001;93:1822-1823.
12. Albertsen PC, Walters S, Hanley JA. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 2000;163:519-523.
13. Wilkins KB, Sheikh E, Green R, et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 1999;230:562-574. (Pubitemid 30191851)
14. Welsh JS, Wilkins KB, Green R, et al. Association between thymoma and second neoplasms. JAMA 2000;283:1142-1143.
15. Gelman R, Gelber R, Henderson IC, et al. Improved methodology for analyzing local and distant recurrence. J Clin Oncol 1990;8:548-555. (Pubitemid 20087556)
16. Regnard J-F, Magdeleinat P, Dromer C, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996;112:376-384. (Pubitemid 26301849)
17. Lewis JE, Wick MR, Scheithauer BW, et al. Thymoma: a clinicopathologic review. Cancer 1987;60:2727-2743.
18. Maggi G, Casadio C, Cavallo A, et al. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991;51:152-156.
19. Blumberg D, Port JL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995;60:908-914.
20. Ruffini E, Mancuso M, Oliaro A, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 1997;113:55-63. (Pubitemid 27034342)
21. Huang J, Rizk NP, Travis WD, et al. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg 2009; 138:26-31.
22. Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985;55: 1074-1086.
23. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004; 77:1860-1869.
24. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247.
25. Erasmus JJ, Gladish GW, Broemeling L, et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003;21:2574-2582. (Pubitemid 46606340)
26. Schwartz LH, Ginsberg MS, DeCorato D, et al. Evaluation of tumor measurements in oncology: use of film-based and electronic techniques. J Clin Oncol 2000;18:2179-2184. (Pubitemid 30324371)
27. Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004;15:257-260. (Pubitemid 38262625)
28. Therasse P, Arbuck SG, Eisenhauer EA, et al. New Guidelines to Evaluate the Response to Treatment in Solid Tumors. J Natl Cancer Inst 2000;92:205-216. (Pubitemid 30099779)
29. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncolong. Br J Cancer 1994;69:979-985. (Pubitemid 24161844)
30. Altman DG, Lausen B, Sauerbrei W, et al. Dangers of using optimal cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994;86:829-835. (Pubitemid 2100935)
31. Grunkemeier GL, Wu Y. Bootstrap resampling methods: something for nothing? Ann Thorac Surg 2004;77:1142-1144. (Pubitemid 38452333)
32. Soper DS. Statistics Knowledge Base-A-Priori Sample Size for Multiple Regression. 2010. Available at: http:www.danielsoper.com/statkb/ topic01.aspx.